Cartesian Therapeutics, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Cartesian Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 149 %.
  • Cartesian Therapeutics, Inc. annual Return On Equity for 2023 was 366 %, a 739% increase from 2022.
  • Cartesian Therapeutics, Inc. annual Return On Equity for 2022 was 43.7 %, a 91.5% decline from 2021.
  • Cartesian Therapeutics, Inc. annual Return On Equity for 2021 was 514 %, a 12% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 366 +323 +739% Jan 1, 2023 Dec 31, 2023
2022 43.7 -470 -91.5% Jan 1, 2022 Dec 31, 2022
2021 514 -70 -12% Jan 1, 2021 Dec 31, 2021
2020 584 +882 Jan 1, 2020 Dec 31, 2020
2019 -298 +119 +28.6% Jan 1, 2019 Dec 31, 2019
2018 -417 -307 -277% Jan 1, 2018 Dec 31, 2018
2017 -111 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.